Document Detail


Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center.
MedLine Citation:
PMID:  10352647     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Charts of 180 patients (147 women, 33 men) with systemic lupus erythematosus (SLE) complicated by renal involvement were retrospectively analyzed from a series of 436 patients. Mean age at renal disease onset was 27 years. Thirty-six percent of the patients had renal involvement after diagnosis of lupus, for 30.7% of that group it was more than 5 years later. Renal involvement occurred more frequently in young male patients of non-French non-white origin. Patients with renal involvement suffered more commonly from malar rash, psychosis, myocarditis, pericarditis, lymphadenopathy, and hypertension. Anemia, low serum complement, and raised anti-dsDNA antibodies were more frequent. According to the 1982 World Health Organization classification, histologic examination of initial renal biopsy specimen in 158 patients showed normal kidney in 1.5% of cases, mesangial in 22%, focal proliferative in 22%, diffuse proliferative in 27%, membranous in 20%, chronic sclerosing glomerulonephritis in 1%, and other forms of nephritis in 6.5%. Distribution of initial glomerulonephritis patterns was similar whether renal involvement occurred before or after the diagnosis of lupus. Transformation from 1 histologic pattern to another was observed in more than half of the analyzable patients (those who underwent at least 2 renal biopsies). Nephritis evolved toward end-stage renal disease in 14 patients despite the combined use of steroids and cyclophosphamide in 12. Initial elevated serum creatinine levels, initial hypertension, non-French non-white origin, and proliferative lesions on the initial renal biopsy were indicators of poor renal outcome. Twenty-four patients died after a mean follow-up of 109 months from SLE diagnosis. Among our 436 patients, the 10-year survival rate was not significantly affected by the presence or absence of renal involvement at diagnosis (89% and 92%, respectively).
Authors:
D L Huong; T Papo; H Beaufils; B Wechsler; O Blétry; A Baumelou; P Godeau; J C Piette
Related Documents :
17644367 - Longitudinal follow-up of systemic inflammation after acute exacerbations of copd.
18209397 - Sustained remission in a case of lupus nephritis with cyclosporin therapy.
2596477 - Tubulointerstitial nephritis due to vancomycin.
21189437 - 25-hydroxyvitamin d deficiency in kidney transplant recipients.
10975317 - Detection of urographic scars in girls with pyelonephritis followed for 13-38 years.
3291267 - New approaches in the use of cyclosporine: with particular reference to the liver.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medicine     Volume:  78     ISSN:  0025-7974     ISO Abbreviation:  Medicine (Baltimore)     Publication Date:  1999 May 
Date Detail:
Created Date:  1999-06-17     Completed Date:  1999-06-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985248R     Medline TA:  Medicine (Baltimore)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  148-66     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Age Factors
Age of Onset
Anti-Inflammatory Agents / therapeutic use
Biopsy
Cause of Death
Child
Creatinine / blood
Female
Follow-Up Studies
Humans
Immunosuppressive Agents / therapeutic use
Kidney Failure, Chronic / etiology
Lupus Nephritis* / metabolism,  mortality,  pathology,  therapy
Male
Middle Aged
Predictive Value of Tests
Prednisone / therapeutic use
Prevalence
Proteinuria / etiology
Retrospective Studies
Survival Analysis
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Immunosuppressive Agents; 53-03-2/Prednisone; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of age on characteristics of polymyositis and dermatomyositis in adults.
Next Document:  Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospe...